THCT · As filed with the SEC

THC Therapeutics income statement, by quarter

The statement as THC Therapeutics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENT OF OPERATIONS · USD, except per-share amounts

USD, except per-share amounts	Q4 FY24^† 3 months ended Jul 31, 2024	Q3 FY24 3 months ended Apr 30, 2024	Q2 FY24 3 months ended Jan 31, 2024	Q1 FY24 3 months ended Oct 31, 2023	Q4 FY23^† 3 months ended Jul 31, 2023	Q3 FY23^† 3 months ended Apr 30, 2023	Q2 FY23^† 3 months ended Jan 31, 2023	Q1 FY23 3 months ended Oct 31, 2022
Revenue	0^†	0	0	0	0^†	0	0	0
Cost of Revenue	0^†	0	0	0	0^†	0	0	0
Gross profit	0^†	0	0	0	0^†	0	0	0
Operating expenses
Professional Fees	80,524^†	148,415	30,738	6,960	(80,710)^†	7,159	102,825	31,552
Consulting fees	—	—	—	—	(500)^†	500	65,890	21,280
Consulting fees	—	—	—	0	—	—	—	—
Labor and Employee Benefits	(281,332)^†	222,000	46,938	46,937	46,937^†	46,937	46,938	46,937
Selling, General and Administrative Expense	—	—	—	—	—	3,424	58,026	7,793
Selling, General and Administrative Expense	222,716^†	9,283	7,475	1,321	1,254^†	3,424^†	58,026^†	—
Total operating expenses	21,908^†	379,698	85,151	55,218	54,651^†	58,020	273,679	107,562
Loss from operations	(21,908)^†	(379,698)	(85,151)	(55,218)	(54,651)^†	(58,020)	(273,679)	(107,562)
Other income (expense)
Non-Operating Income (Expense)	(173,060)^†	502,657	(467,154)	12,113	41,875^†	171,604	1,979,597	(2,008,933)
Interest Expense	0^†	0	0	0	0^†	0	0	2,310
Interest expense	(86,756)^†	(18,337)	(19,670)	(19,380)	(20,165)^†	(19,229)	(20,066)	(20,117)
Total other income (expense)	—	—	—	—	—	152,375	1,959,531	(2,026,740)
Net income (loss)	—	—	—	—	—	94,355	1,685,852	—
Total other income (expense)	(259,816)^†	484,320	(486,824)	(7,267)	21,710^†	152,375^†	1,959,531^†	—
Net income (loss)	(281,724)^†	104,622	(571,975)	(62,485)	(32,941)^†	94,355^†	1,685,852^†	(2,134,302)
Basic loss per common share	—	—	0.06	0.00	—	0.00	0.05	—
Basic weighted average common shares outstanding	—	—	32,865,868	32,746,149	—	32,746,149	32,746,149	—
Earnings Per Share (Basic)	—	0.00	—	—	—	—	—	(0.06)
Weighted Average Shares Outstanding	—	38,334,816	—	—	—	—	—	32,865,868

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.